Results 91 to 100 of about 333 (103)

Maintenance Acne Treatment with Topical Tazarotene after Oral Isotretinoin: Overview and Case Reports. [PDF]

J Clin Aesthet Dermatol
Miranti SM.
europepmc   +1 more source

Efficacy of Topical Treatments in the Management of Mild-to-Moderate Acne Vulgaris: A Systematic Review. [PDF]

Cureus
Althwanay A, AlEdani EM, Kaur H, Kasapoglu M, Yadavalli R, Nawaz S, Nath TS.   +6 more
europepmc   +1 more source

Acne Vulgaris in Children and Adolescents: What's the Cause and How to Combat It. [PDF]

J Pediatr Pharmacol Ther
Palmieri SA.
europepmc   +1 more source

Efficacy of Topical Tretinoin and Topical Minoxidil Cotherapy in Androgenetic Alopecia: A Review. [PDF]

Skin Appendage Disord
Maas D, Spindler A, Zappi I, Maas K, Brody A, Tucci C, Garza-García L, Patrocínio J, Shapiro J, Lo Sicco KI.   +9 more
europepmc   +1 more source

Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne [PDF]

Journal of the American Academy of Dermatology, 2019
BACKGROUND: Acne vulgaris often affects the face, shoulders, chest, and back, but treatment of nonfacial acne has not been rigorously studied. OBJECTIVES: Assess the safety and efficacy of trifarotene 50 μg/g cream, a novel topical retinoid, in moderate ...
Sandra Johnson, Jerry Tan, Ulrike Blume-Peytavi   +2 more
exaly   +3 more sources

Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation

International Journal of Dermatology
BACKGROUND: Acne-induced hyperpigmentation (AIH) may accompany acne vulgaris (AV) inflammation in all skin phototypes. Trifarotene has shown depigmenting properties in vivo.
Rajeev Chavda
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Trifarotene for the Treatment of Facial and Truncal Acne

Annals of Pharmacotherapy, 2021
Wasim Haidari, Katheryn A Bell
exaly  

Clinical Pharmacology and Safety of Trifarotene, a First‐in‐Class RARγ‐Selective Topical Retinoid

Journal of Clinical Pharmacology, 2020
exaly  

Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne

Bioorganic and Medicinal Chemistry Letters, 2018
Claire Bouix-Peter, Gilles Ouvry
exaly  

Trifarotene

American Journal of Health-System Pharmacy, 2020
exaly